Posted Date
Effective Date
Update Type Test Methodology Changed
Order Code EPC2

REVISIONS TO PROFILE AND REFLEX COMPONENTS

 

Epilepsy, Autoimmune Evaluation, CSF

Order Code:                  EPC2

Fee Code:                     AA276 (CPT 86341), AA277 (CPT 86255) x16

Reference Laboratory:   Mayo EPC2

 

Effective January 31, 2023, there will be additions and deletions to the profile and potential reflex tests for the Epilepsy, Autoimmune Evaluation, CSF referred to Mayo Clinic Laboratories as follows:

 

Testing to be added to Profile:

• NCDIC: Neurochondrin Antibody, Tissue Immunofluorescence, Spinal Fluid (CPT 86255)

 

Testing to be added to Reflex Tests:

• AGNTC: Anti-Glial/Neuronal Nuclear Antibody-Type 1 (AGNA-1) Titer, Spinal Fluid

• AN1TC: Antineuronal Nuclear Antibody-Type 1 (ANNA-1) Titer, Spinal Fluid

• AN2TC: Antineuronal Nuclear Antibody Type 2 (ANNA-2) Titer, Spinal Fluid

• AN3TC: Antineuronal Nuclear Antibody Type 3 (ANNA-3) Titer, Spinal Fluid

• APHTC: Amphiphysin Antibody Titer Assay, Spinal Fluid

• CRMTC: Collapsin Response-Mediator Protein-5 (CRMP-5) Neuronal IgG Titer, Spinal Fluid

• NCDCC: Neurochondrin Antibody, Cell-Binding Assay, Spinal Fluid

• NCDTC: Neurochondrin Antibody, Tissue Immunofluorescence Titer, Spinal Fluid

• PC2TC: Purkinje Cell Cytoplasmic Antibody Type 2 (PCA-2) Titer, Spinal Fluid

• PCTTC: Purkinje Cell Cytoplasmic Antibody, Type Tr (PCA-Tr) Titer, Spinal Fluid

 

Testing to be removed from Reflex Tests:

• PC1BC: Purkinje Cell Cytoplasmic Antibody-Type 1, Immunoblot, Spinal Fluid

• PCA1C: Purkinje Cell Cytoplasmic Antibody, Type 1 (PCA-1), Spinal Fluid